NCT00383539View on ClinicalTrials.gov

Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

2,256

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

December 31, 2007

Conditions
Orthomyxoviridae InfectionInfluenzaMyxovirus Infection
Interventions
BIOLOGICAL

Inactivated Split-virion influenza vaccine

Vaccine Lot 1

BIOLOGICAL

Inactivated Split-virion influenza vaccine

Vaccine Lot 2

BIOLOGICAL

Inactivated Split-virion influenza vaccine

Vaccine Lot 3

BIOLOGICAL

Inactivated Split-virion influenza vaccine

Control Vaccine

Trial Locations (4)

28041

Madrid

49000

Angers

08117

Vilnius

Unknown

Bath

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00383539 - Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults | Biotech Hunter | Biotech Hunter